Announcements Trials
Browse Landscape

Phase

Phase 1 19Phase 2 8Phase EARLY_PHASE1 6Phase 1/2 5Phase 4 2Phase NA 1Phase 3 1

Status

Completed 36Recruiting 32Unknown 27Terminated 14Withdrawn 12Active not recruiting 12Not yet recruiting 5Suspended 1

Sponsor Class

INDUSTRY 3OTHER_GOV 1OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 1

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 20Neoplasms 19Colorectal Neoplasms 19Recurrence 17Pancreatic Neoplasms 17Multiple Myeloma 15Advanced Solid Tumors 13Prostatic Neoplasms 12Advanced Solid Tumor 12Stomach Neoplasms 10Ovarian Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Hepatocellular 10Triple Negative Breast Neoplasms 8Neoplasm Metastasis 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Solid Tumor 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Endometrial Neoplasms 5

Interventions

venetoclax 1obinutuzumab 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Lymphoma, B-Cell × Clear all
NCT07520006 2026-04-13

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

Nurix Therapeutics, Inc.

Phase 1/2 Not yet recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07506668 2026-04-02

RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Affiliated Hospital of Nantong University

Phase 1/2 Not yet recruiting
10 enrolled
Lymphoid

Lymphoma, B-Cell

NCT07439653 2026-02-27

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

TORL Biotherapeutics, LLC

Phase 1/2 Not yet recruiting
155 enrolled
Lymphoid

Lymphoma, B-Cell

NCT07162571 2025-09-09

MSTH-CAR002

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology

Phase 1/2 Not yet recruiting
17 enrolled
Lymphoid

Lymphoma, B-Cell

NCT05091541 2021-10-25

A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Nanjing IASO Biotechnology Co., Ltd.

Phase 1/2 Not yet recruiting
125 enrolled
Lymphoid

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡